3,4-di-substituted maleimide compounds as CXC chemokine receptor antagonists

摘要

Disclosed are compounds of the formula (I) or a pharmaceutically acceptable salt or solvate thereof. The compounds are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.